Differential Control of TGM2 Expression by Oestrogen Receptor/SERMs.

D McDonnell, Selective estrogen receptor modulators (SERMs): A first step in the development of perfect hormone replacement therapy regimen. Journal of The Society for Gynecologic Investigation. ,vol. 7, pp. 10- 15 ,(2000) , 10.1016/S1071-5576(99)00055-6

S. R. Cummings, The effect of raloxifene on risk of breast cancer in postmenopausal women : results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation JAM. ,vol. 281, pp. 2189- 2197 ,(1999)

Stephen Safe, Kyounghyun Kim, Nuclear receptor-mediated transactivation through interaction with Sp proteins. Progress in Nucleic Acid Research and Molecular Biology. ,vol. 77, pp. 1- 36 ,(2004) , 10.1016/S0079-6603(04)77001-4

H. Gronemeyer, Vincent Laudet, The nuclear receptor factsbook Academic Press. ,(2002)

Stephen Nussey, Saffron A. Whitehead, Endocrinology: An Integrated Approach ,(2001)

V Gentile, M Saydak, E A Chiocca, O Akande, P J Birckbichler, K N Lee, J P Stein, P J Davies, Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. Journal of Biological Chemistry. ,vol. 266, pp. 478- 483 ,(1991) , 10.1016/S0021-9258(18)52460-1

A. Ichinose, R.E. Bottenus, E.W. Davie, Structure of transglutaminases. Journal of Biological Chemistry. ,vol. 265, pp. 13411- 13414 ,(1990) , 10.1016/S0021-9258(18)77358-4

M G Kinsella, T N Wight, Formation of high molecular weight dermatan sulfate proteoglycan in bovine aortic endothelial cell cultures. Evidence for transglutaminase-catalyzed cross-linking to fibronectin. Journal of Biological Chemistry. ,vol. 265, pp. 17891- 17898 ,(1990) , 10.1016/S0021-9258(18)38247-4

B.M. Weichman, A.C. Notides, Estradiol-binding kinetics of the activated and nonactivated estrogen receptor. Journal of Biological Chemistry. ,vol. 252, pp. 8856- 8862 ,(1977) , 10.1016/S0021-9258(17)38319-9

Benita S. Katzenellenbogen, Stuart W. Peltz, Mary Jane Norman, Richard L. Eckert, Walter F. Mangel, Bioactivities, Estrogen Receptor Interactions, and Plasminogen Activator-inducing Activities of Tamoxifen and Hydroxy-tamoxifen Isomers in MCF-7 Human Breast Cancer Cells Cancer Research. ,vol. 44, pp. 112- 119 ,(1984)